Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Deciphera Pharmaceuticals LLC stock

Learn how to easily invest in Deciphera Pharmaceuticals LLC stock.

Deciphera Pharmaceuticals LLC is a drug manufacturers-specialty & generic business based in the US. Deciphera Pharmaceuticals LLC shares (DCPH) are listed on the NASDAQ and all prices are listed in US Dollars. Deciphera Pharmaceuticals LLC employs 300 staff and has a trailing 12-month revenue of around $138.3 million.

How to buy Deciphera Pharmaceuticals LLC stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DCPH. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for all-in-one investing

M1 Finance

  • Commission-free stock and ETF trades
  • No management fees
  • Customizable portfolios with automatic rebalancing

Deciphera Pharmaceuticals LLC stock price (NASDAQ: DCPH)

Use our graph to track the performance of DCPH stocks over time.

Deciphera Pharmaceuticals LLC shares at a glance

Information last updated 2023-06-04.
Latest market close$14.08
52-week range$10.14 - $22.76
50-day moving average $14.42
200-day moving average $16.14
Wall St. target price$21.33
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.25

Buy Deciphera Pharmaceuticals LLC stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
M1 Finance
Stocks, ETFs
Get $75 - $500
when you sign up and deposit min. $10,000 within 14 days. Terms and conditions apply
Build a custom portfolio of stocks and ETFs with automatic rebalancing.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency, Alternatives, Treasury Bills
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Earn a 5.4% yield with government-backed Treasury bills.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Deciphera Pharmaceuticals LLC stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Deciphera Pharmaceuticals LLC price performance over time

Historical closes compared with the close of $14.08 from 2023-06-02

1 week (2023-05-30) 3.53%
1 month (2023-05-05) 4.14%
3 months (2023-03-06) -6.69%
6 months (2022-12-06) -6.51%
1 year (2022-06-03) 25.60%
2 years (2021-06-04) -57.22%
3 years (2020-06-05) 55.19
5 years (2018-06-06) 41.52

Deciphera Pharmaceuticals LLC financials

Revenue TTM $138.3 million
Gross profit TTM $-62,555,000
Return on assets TTM -25.29%
Return on equity TTM -51.05%
Profit margin -131.38%
Book value $5.61
Market capitalisation $1.1 billion

TTM: trailing 12 months

Deciphera Pharmaceuticals LLC share dividends

We're not expecting Deciphera Pharmaceuticals LLC to pay a dividend over the next 12 months.

Deciphera Pharmaceuticals LLC share price volatility

Over the last 12 months, Deciphera Pharmaceuticals LLC's shares have ranged in value from as little as $10.14 up to $22.76. A popular way to gauge a stock's volatility is its "beta".

DCPH.US volatility(beta: 0.67)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Deciphera Pharmaceuticals LLC's is 0.6749. This would suggest that Deciphera Pharmaceuticals LLC's shares are less volatile than average (for this exchange).

Deciphera Pharmaceuticals LLC overview

Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company, engages in the discovering, developing, and commercializing medicines to improve the lives of cancer patients in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 in combination with RTK/RAS/MAP kinase signaling pathway inhibition to treat RAS/RAF mutant cancers. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. .

Frequently asked questions

What percentage of Deciphera Pharmaceuticals LLC is owned by insiders or institutions?
Currently 29.987% of Deciphera Pharmaceuticals LLC shares are held by insiders and 73.087% by institutions.
How many people work for Deciphera Pharmaceuticals LLC?
Latest data suggests 300 work at Deciphera Pharmaceuticals LLC.
When does the fiscal year end for Deciphera Pharmaceuticals LLC?
Deciphera Pharmaceuticals LLC's fiscal year ends in December.
Where is Deciphera Pharmaceuticals LLC based?
Deciphera Pharmaceuticals LLC's address is: 200 Smith Street, Waltham, MA, United States, 02451
What is Deciphera Pharmaceuticals LLC's ISIN number?
Deciphera Pharmaceuticals LLC's international securities identification number is: US24344T1016
What is Deciphera Pharmaceuticals LLC's CUSIP number?
Deciphera Pharmaceuticals LLC's Committee on Uniform Securities Identification Procedures number is: 24344T101

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site